Tag: Cancer: Lymphoma
Early Intervention May Reduce Breast CA-Related Lymphedema
Bioimpedance spectroscopy monitoring with early interventions lowers need for aggressive treatment
Breast Implants Slightly Increase Risk of Breast ALCL
Implants tied to increased risk of anaplastic large-cell lymphoma; overall risk still very small
ASH: A+AVD Beats ABVD for Advanced Hodgkin’s Lymphoma
Lower combined risk of progression, death, or noncomplete response with A+AVD
ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas
Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma
Lymphoma Risk Up With Thiopurine, Anti-TNF Tx in IBD
Risk higher for those exposed to combination therapy versus thiopurine or anti-TNF monotherapy
Calquence Approved for Mantle Cell Lymphoma
For patients who have not responded to at least one prior treatment or who have relapsed
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma
Assay assesses expression of 21 markers, classifies most samples into expected subtype
Gene Tx Approved for Certain Types of B-Cell Lymphoma
First such treatment for certain types of non-Hodgkin lymphoma
PFS Up With Obinutuzumab-Based Tx in Follicular Lymphoma
Induction, maintenance treatment with obinutuzumab-based chemo beats rituximab
FDA Approves Aliqopa for Follicular Lymphoma
Aliqopa, a kinase inhibitor, blocks several enzymes that promote cell growth
